In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Rodrigo Estevez Loureiro
Rodrigo Estevez Loureiro
Rodrigo Estevez Loureiro Rodrigo Estevez Loureiro

University Hospital Alvaro Cunqueiro, Vigo (Spain)

Speciality : Interventional Cardiology

Trained as Interventional Cardiologist at the Hospital of A Coruña. Transcatheter Valve Therapies Fellow at Royal Brompton Hospital (London). Currently, consultant of Interventional Cardiology at University Hospital Álvaro Cunqueiro in Vigo, Spain. PhD degree from the University of La Coruña with a work related to STEMI networks. Certificate of Advanced Studies in structural aortic, mitral and tricuspid interventions by University of Zurich. Leader of transcatheter mitral and tricuspid valve programs at University Hospital Álvaro Cunqueiro (Vigo, Spain). Leader of the LAAC program. Fellow of the European Society of Cardiology. More than 100 published articles, book chapters and numerous presentations at national and international congresses. Active member of the Sentinel registries of the ESC on transcatheter valve therapies. Main lines of research in ST-segment elevation myocardial infarction and transcatheter mitral and tricuspid valve repair/replacement and LAA occlusion.

2 presentations from this speaker

Effect of TR grade on outcomes and evolution of TR 1 year after TMVr: results from the Global EXPAND Study

Event : EACVI Best of Imaging 2020

  • Session : Late Breaking Trials in Cardiovascular Imaging in 2020
  • Speaker : R Estevez Loureiro (Vigo,ES)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are